Vitamin B12 Supplement to Prevent Cognitive Decline

Status Completed

Clinical Trial Summary

Background: Older diabetic people are at greater risk of cognitive decline than non-diabetic people. Vitamin B12 deficiency in older people is associated with cognitive impairment and Alzheimer's disease. Vitamin B12 deficiency may therefore contribute to cognitive decline in older diabetic people.

Objective: To determine whether the correction of mild vitamin B12 deficiency in cognitively normal older diabetic people reduces the incidence of cognitive decline.

Design: randomized, double blind, placebo controlled trial Subject: Cognitively normal diabetic outpatients aged 70 years or older with plasma vitamin B12 150-300 pmol/L in medical and family medicine/ general outpatient clinics.

Procedure: After excluding those with clinical manifestations of vitamin B12 deficiency and without family member who can reliably inform on cognitive functioning (personal contact at least once a week), eligible patients will be invited to participate in this clinical trial. After obtaining written consent, research assistant (RA) will record demographic and clinical information from the subjects and perform neuropsychological tests - 1. Clinical dementia rating scale (CDR), 2. neurocognitive test battery (see below) 3. Chinese Mini mental state examination (MMSE), 4. Geriatric depression scale (GDS). Fasting blood will be taken for serum methylmalonic acid (MMA). Those with cognitive impairment and significant comorbidities will be excluded.

264 eligible subjects will be randomly assigned to take either two Vitamin B12 500 microgram or two identical looking placebo tablets once daily for 27 months.

All subjects or family caregivers are reviewed in the research clinic every 12 weeks in which the research assistant performs a pill count and dispenses the trial tablets. At 9 monthly intervals, the subjects will have neurocognitive test battery repeated at research clinic. CDR will be repeated at month 18 and 27. At month 9 and 27, fasting serum MMA and vitamin B12 will be repeated.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02457507
Study type	Interventional
Source	Chinese University of Hong Kong
Contact
Status	Completed
Phase	Phase 4
Start date	August 2011
Completion date	January 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03228446` - The Effects of Attentional Filter Training on Working Memory	N/A
Completed	`NCT04033419` - Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer	Phase 2
Terminated	`NCT05199142` - A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SDI-118 in Elderly Male and Female Study Participants With Cognitive Decline	Phase 1
Active, not recruiting	`NCT05290233` - Time Restricted Eating Plus Exercise for Weight Management	N/A
Terminated	`NCT03337282` - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Unknown status	`NCT00696514` - Vitamin B12 and Folic Acid Supplementation for Preventing Fractures in Elderly People	Phase 1
Completed	`NCT00110604` - The Effect of Folic Acid on Atherosclerosis, Cognitive Performance and Hearing	N/A
Recruiting	`NCT06245005` - Preoperative Cognitive Reserve in Older Surgical Patients: A Feasibility Study
Recruiting	`NCT05014399` - Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Active, not recruiting	`NCT05586750` - Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy	Phase 4
Completed	`NCT04386902` - Evaluation of Cognitive State Using Neurosteer EEG System
Recruiting	`NCT06070818` - Healthy Body & Mind Program for Older Adults Living With Osteoarthritis and Cognitive Decline	N/A
Completed	`NCT01669915` - A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline	N/A
Completed	`NCT02814526` - Exercise in Adults With Mild Memory Problems	N/A
Not yet recruiting	`NCT05928078` - A Home-based e-Health Intervention in the Elderly: MOVI-ageing	N/A
Not yet recruiting	`NCT06252376` - Effects of Blood Pressure on Cognition and Cerebral Hemodynamics in PD	N/A
Recruiting	`NCT06318377` - Peanuts and Neurocognitive / Cardiovascular Health in Black Individuals	N/A
Recruiting	`NCT03839784` - Building a Platform for Precision Anesthesia in the Geriatric Surgical Patient
Completed	`NCT04537728` - My Healthy Brain: Preserving and Promoting Brain Health Through Evidence-based Practices	N/A
Active, not recruiting	`NCT03370796` - Group Reminiscence Therapy for Elderly People With Cognitive Decline in Institutional Context	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.